These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6257384)

  • 21. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
    Hodes RJ; Novick MB; Palmer LD; Knepper JE
    J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virus-dependent cytostatic activity to mammary tumor cells of lymphocytes from normal mice.
    Gillette RW; Lowery LT
    Cancer Res; 1976 Nov; 36(11 Pt 1):4008-14. PubMed ID: 184922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro detection of immune responses to MTV-induced mammary tumors: activity of spleen cell preparations from both MTV-free and MTV-infected mice.
    Blair PB; Lane MA; Yagi MJ
    J Immunol; 1974 Feb; 112(2):693-705. PubMed ID: 4360546
    [No Abstract]   [Full Text] [Related]  

  • 24. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer.
    Stutman O
    Cancer Res; 1976 Feb; 36(2 pt 2):739-47. PubMed ID: 175934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammary cancer stages in BALB/cV mice: mouse mammary tumor virus expression and virus-host interactions.
    Slagle BL; Medina D; Butel JS
    J Natl Cancer Inst; 1987 Aug; 79(2):323-35. PubMed ID: 3037152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recipient polyclonal B cell activation and immunoglobulin production induced by priming with a retroviral superantigen.
    Modlin CS; Muruve NA; Stanko D; Caulfield MJ; Fairchild RL
    Cell Immunol; 1996 May; 169(2):252-63. PubMed ID: 8620553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse mammary tumor virus (MMTV) antigen(s) are present on B lymphocytes of BALB/c mice.
    Charyulu V; Sigel MM; Durden DL; Lopez DM
    Int J Cancer; 1979 Dec; 24(6):813-8. PubMed ID: 94593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-T cell killing of mammary tumor cells by spleen cells: secretion of antibody and recruitment of cells.
    Blair PB; Lane MA
    J Immunol; 1975 Jul; 115(1):184-9. PubMed ID: 168254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naturally occurring lymphocyte reactivity to purified mammary tumor virus antigens.
    Gillette RW; Lowery LT
    J Reticuloendothel Soc; 1977 Jan; 21(1):1-6. PubMed ID: 191607
    [No Abstract]   [Full Text] [Related]  

  • 30. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance.
    Modlin CS; Todd GT; Cohen TD; Fairchild RL
    Cell Immunol; 1995 Sep; 164(2):217-26. PubMed ID: 7656330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells.
    Ritzi EM; Smith BA; Stolfi RL; Martin DS
    Cancer Res; 1981 Oct; 41(10):3885-90. PubMed ID: 6269731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage migration inhibition and lymphocyte stimulation with mammary tumor virus associated antigens in Balb/c mice.
    Lopez DM; Ortiz-Muniz G; Sigel MM
    Proc Soc Exp Biol Med; 1976 Jan; 151(1):225-30. PubMed ID: 175373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural immunity in the oncornavirus-infected mouse.
    Blair PB
    Cancer Res; 1976 Feb; 36(2 pt 2):734-8. PubMed ID: 175933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-preventive effects of the soluble p53 antigen on chemically-induced skin cancer in mice.
    Ben-Hur H; Ben-Meir A; Hagay Z; Ben-Meir A; Berman V; Schwartsburd B; Gurevich P; Sandler B; Tendler Y; Zinder O; Zusman I
    Anticancer Res; 1998; 18(6A):4237-41. PubMed ID: 9891473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells.
    Ardavín C; Waanders G; Ferrero I; Anjuère F; Acha-Orbea H; MacDonald HR
    J Immunol; 1996 Oct; 157(7):2789-94. PubMed ID: 8816381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonspecific T-cell reactivity in mice bearing autochthonous tumors or early-generation transplanted spontaneous mammary tumors.
    Parthenais E; Haskill S
    J Natl Cancer Inst; 1979 Jun; 62(6):1569-74. PubMed ID: 312353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of lymphoid cells responding to virus- and tumor-associated antigens in spleens of syngeneic mouse mammary tumor systems with low and high oncogenic potentials.
    Lopez DM; Paul RD
    J Natl Cancer Inst; 1982 Dec; 69(6):1403-9. PubMed ID: 6292565
    [No Abstract]   [Full Text] [Related]  

  • 38. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity.
    Papiernik M; do Carmo Leite-de-MoraesM ; Pontoux C; Joret AM; Rocha B; Penit C; Dy M
    J Immunol; 1997 May; 158(10):4642-53. PubMed ID: 9144476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunology of the mouse mammary tumor virus: comparison of mammary tumor virus with the agent found in C3Hf/Crgl mice.
    Blair PB; Weiss DW
    J Natl Cancer Inst; 1966 Mar; 36(3):423-9. PubMed ID: 18630318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In situ lymphoid cells of mouse mammary tumors. IV. Comparison of functional activity of lymphoid cells separated from mammary tumors to that of spleen and lymph node cells of tumor-sensitized mice.
    Ruppert B; Blazar B; Medina D; Heppner G
    J Immunol; 1979 Jun; 122(6):2180-3. PubMed ID: 448122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.